Cardiac conduction system disease
- Human trial1
Interventions
1Intensive blood pressure control
no changein humans1
1 study
Intensive blood pressure control
no changein humans1
Intensive blood pressure control has no effect on cardiac conduction system disease in humans (6.42% vs 5.94%).
“The incidence of new-onset CSD was similar in the intensive (n = 205, 6.42%) and standard (n = 188, 5.94%) treatment arms.”
Human trialin elderly hypertensive patients
Incidence and prognosis of cardiac conduction system diseases in hypertension: the STEP trial
Nature aging21 Mar 2024
Associations
2Body mass index
upin humans1
1 study
Body mass index
upin humans1
Body mass index is associated with cardiac conduction system disease in humans.
“Increased age, male sex and increased body mass index were independently associated with increased risk for new-onset CSD.”
Human trialin elderly hypertensive patients
Incidence and prognosis of cardiac conduction system diseases in hypertension: the STEP trial
Nature aging21 Mar 2024
Acute decompensated heart failure
upin humans1
1 study
Acute decompensated heart failure
upin humans1
Cardiac conduction system disease raises the risk of acute decompensated heart failure in humans.
“Participants with preexisting CSD had a higher risk for acute decompensated heart failure.”
Human trialin elderly hypertensive patients
Incidence and prognosis of cardiac conduction system diseases in hypertension: the STEP trial
Nature aging21 Mar 2024